Safety & Effectiveness of TENS Weight Management Compared to a Sham
NCT05675384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 395
Last updated 2024-07-31
Summary
This is a multicenter, randomized, blinded, parallel group, controlled study intended to evaluate the safety and effectiveness of treating overweight and Class 1 obese patients with the Elira System (TENS active treatment) combined with a moderate intensity lifestyle follow-up compared to participants using the sham (control) device combined with a moderate intensity lifestyle follow-up
Conditions
- Obesity, Mild
Interventions
- DEVICE
-
TENS Active Treatment
Using a 7-day/week wearable TENS device controlled by a Smart Phone App combined with moderate intensity lifestyle therapy,
- DEVICE
-
Sham Device
Using the sham (control) device combined with a moderate intensity lifestyle follow-up
Sponsors & Collaborators
-
Elira, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-29
- Primary Completion
- 2024-07-23
- Completion
- 2024-07-23
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
NCT02243202 ·Status: COMPLETED ·Phase: PHASE2
-
Lifestyle Modification and Liraglutide
NCT02911818 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
NCT05616013 ·Status: COMPLETED ·Phase: PHASE2
-
To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
NCT03795701 ·Status: COMPLETED ·Phase: NA
-
Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
NCT04408586 ·Status: COMPLETED ·Phase: PHASE4
-
Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
NCT01834404 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method
NCT01853397 ·Status: COMPLETED ·Phase: NA
-
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Pharmacological Stimulation of BAT and WAT in Lean and Obese Young Adults
NCT02354807 ·Status: UNKNOWN ·Phase: PHASE2
-
Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
NCT03757130 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
NCT06603571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
NCT02918279 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
Adolescent Weight Management Study
NCT00212173 ·Status: COMPLETED ·Phase: NA
-
Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients
NCT02041195 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
NCT06047548 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
NCT07150975 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Injection in Non-diabetic Overweight or Obese Adult Subjects
NCT06714955 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
NCT05579249 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
NCT06643728 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Auricular Acupuncture in the Treatment of Obesity
NCT02269371 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers
NCT02431442 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants
NCT01749137 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
NCT02870231 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
NCT06299098 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2